Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.1M Buy
+280,000
New +$50.7M 0.26% 53
2026
Q1
Sell
-12,500
Closed -$2.44M 1951
2025
Q4
$2.44M Buy
+12,500
New +$2.98M 0.02% 707

Other funds holding ORCL

Michael Gelband's ORCL Position: Q2 2026 in Review

Michael Gelband increased its Oracle (ORCL) stake by 19% in Q2 2026, buying an estimated $5.41M and bringing the position to 185,787 shares worth $27.2M. The position accounts for 0.18% of the portfolio, ranked #84.

Michael Gelband first reported a position in ORCL in Q4 2018 and has held it in 23 quarters since. The position peaked at $30.9M in Q1 2024. 3,504 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Michael Gelband held 185,787 shares of Oracle worth $27.2M as of Q2 2026.
  • Michael Gelband bought 29,853 Oracle shares in Q2 2026, an estimated $5.41M.
  • Oracle made up 0.18% of Michael Gelband's portfolio in Q2 2026, its #84 holding.
  • Michael Gelband first reported a position in Oracle in Q4 2018 and has held it in 23 quarters since.
  • Michael Gelband's Oracle position peaked at $30.9M in Q1 2024.
  • 3,504 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.